One of the first questions asked of entrepreneurs by customers and investors is, “How are you going to get paid?” In this workshop, you will learn how the “black box” of the US reimbursement systems works and what are the strategies you will need to execute to ensure your innovative offering has a viable path forward.
The session will consist of interactive didactic sessions as well as case studies. Understanding these concepts is mandatory for any digital health executive and attendance will be limited to a curated group of participants so apply early to maximize your opportunity to participate.
Workshops like these typically cost thousands of dollars. UCSF Health Hub and Dr. Shawn Becker are collaborating to be able to offer a special promotional price to encourage participation from entrepreneurs at all stages of their business.
As the founder and President of Silvercat Advisors, Dr. Becker provides strategic reimbursement and market access counsel for innovative medical device, diagnostic, and digital health companies. Prior to founding his consulting firm, he served as iRhythm Technologies’ Executive Vice President of Marketing and Reimbursement where he conceived and implemented commercial strategies resulting in >50% growth in product revenue. While at iRhythm, Dr. Becker built and led a payer relations team resulting in ~100M incremental covered lives including Aetna, Humana, Blue Shield of California and other commercial payers. Previously, he was Pathwork Diagnostics’ Senior Vice President of Marketing and Reimbursement, where he launched a test to help patients with difficult-to-diagnose cancers. He also co-founded PlanetRx.com, an online pharmacy that became the nation’s #1 most-visited site in the online drugstore category resulting in a successful IPO led by Goldman Sachs. Dr. Becker completed his internship in primary care internal medicine at Massachusetts General Hospital after receiving his M.D. from UCSF and has an A.B. in history and science from Harvard University.
Silvercat Advisors was founded in 2015 with a mission to help patients get access to innovative medical technologies and services. We do this by advising select companies on their commercial and reimbursement strategies. Our domain experience includes medical devices, diagnostics, and digital health, including wearables and digital medicines. Our clients range from early stage ventures all the way to large publicly traded enterprises. All of them, however, are pursuing novel solutions to important unmet needs for which the reimbursement path forward is complex.
